Current status of research on clinical progress management of benign prostatic hyperplasia

doi:10.3969/j.issn.1674-490X.2022.01.010

Abstract

Abstract: In recent years,with the acceleration of aging,the prevalence of benign prostatic hyperplasia(BPH)has shown an increasing trend,seriously affecting the quality of life of elderly men,and at the same time,it has brought an economic burden to the global medical care service system. In order to explore the current status of BPH management methods at home and abroad,an integrated analysis was carried out by searching relevant literature on BPH clinical progress management. At present,in order to delay and change the clinical progress of BPH patients,management methods combining clinical and non-clinical interventions have been adopted at home and abroad,and some results have been achieved,but there are still certain limitations. This paper analyzes and summarizes the current research status, and provides a reliable basis for the management of BPH clinical progress in the later stage.

Key words: benign prostatic hyperplasia, clinical progress, management method

CLC Number:

R699

JIANG Dongxu, ZOU Hao, SUN Min, ZHANG Linlin. Current status of research on clinical progress management of benign prostatic hyperplasia[J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(1): 68-74.

References

[1] MAHON J T, WELLIVER C. National trends in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia[J]. Curr Urol Rep, 2020, 21(12): 63. DOI: 10.1007/s11934-020-01014-w.
[2] 马正君,孙小红.慢病管理对前列腺增生患者生活质量的影响[J].中国医药导报, 2018, 15(21): 51-54.
[3] 吴佼佼,马红梅,廖春霞,等.良性前列腺增生患者抑郁的研究进展[J].中华现代护理杂志, 2016, 22(29): 4281-4284. DOI: 10.3760/cma.j.issn.1674-2907.2016.29.037.
[4] 江钰,胡金霞.中药穴位贴敷配合治疗老年良性前列腺增生症临床疗效分析[J].新疆中医药, 2020, 38(1): 27-29.
[5] 杨双,旷云祥.中药坐熏治疗良性前列腺增生疗效观察[J].天津药学, 2016, 28(3): 29-30. DOI: 10.3969/j.issn.1006-5687.2016.03.011.
[6] 徐桂兴,罗廖君,银子涵,等.基于数据挖掘近10年针灸治疗良性前列腺增生症用穴规律研究[J].世界科学技术-中医药现代化, 2020, 22(4): 1330-1340. DOI: 10.11842/wst.20190409004.
[7] 樊金灼,梁冰,朱连荣.真武汤配合电针治疗良性前列腺增生症的临床观察[J].中华保健医学杂志, 2017, 19(1): 31-33. DOI: 10.3969/.issn.1674-3245.2017.01.009.
[8] 柳春华.艾灸对前列腺增生患者的应用效果及护理评价[J].医学食疗与健康, 2019(15):29,31.
[9] 徐晓倩.艾灸结合穴位按摩对前列腺增生治疗干预的疗效观察[J].北方药学, 2016, 13(8): 189.
[10] 李元锴.前列腺按摩配合针灸治疗前列腺增生症的临床疗效分析[J].实用中西医结合临床, 2019, 19(5): 9-11. DOI: 10.13638/j.issn.1671-4040.2019.05.005.
[11] 黄景智,覃江.良性前列腺增生的外科手术治疗进展[J].医药前沿, 2020, 10(9): 9-10.
[12] 史京,吴越.良性前列腺增生外科治疗进展[J].世界最新医学信息文摘, 2018, 18(43): 114-116. DOI: 10.19613/j.cnki.1671-3141.2018.43.044.
[13] 史涛坪,张旭.经尿道前列腺机器人水刀切除术在治疗良性前列腺增生中的应用[J].微创泌尿外科杂志, 2020, 9(1): 1-5. DOI: 10.19558/j.cnki.10-1020/r.2020.01.001.
[14] 杨华,贾洪涛,司敏.良性前列腺增生的外科治疗进展[J].中国老年保健医学, 2017, 15(3): 61-63. DOI: 10.3969/j.issn.1672-4860.2017.03.028.
[15] 李宁,赵玉梅.良性前列腺增生患者分级管理模式的效果研究[J]. 中国卫生产业, 2016, 13(23): 49-51. DOI: 10.16659/j.cnki.1672-5654.2016.23.049.
[16] 李燕.前列腺增生患者采用优质细节管理的实施效果[J].中国卫生产业, 2018, 15(16): 46-47. DOI: 10.16659/j.cnki.1672-5654.2018.16.046.
[17] 谷现恩,王家菁,张军,等.良性前列腺增生患者分级管理模式的效果研究[J].现代泌尿外科杂志, 2015, 20(2): 86-88. DOI: 10.3969/j.issn.1009-8291.2015-02-005.
[18] 裴丽,刘晓萱,杜红娣,等.基于微信视频的正念减压疗法对老年前列腺增生病人焦虑、抑郁及生活质量的影响[J]. 护理研究, 2019, 33(19): 3436-3439. DOI: 10.12102/j.issn.1009-6493.2019.19.032.
[19] 张倩,黄双丽,胡景贤,等.家庭支持在老年前列腺增生患者自我管理行为中的应用与效果[J].中国医药科学, 2018, 8(12): 152-155. DOI: 10.3969/j.issn.2095-0616.2018.12.049.
[20] 吴杰兰,杨昭.老年良性前列腺增生患者家庭功能与生活质量调查[J].天津护理, 2015, 23(5): 382-384. DOI: 10.3969/j.issn.1006-9143.2015.05.003.
[21] 孙玉果.前列腺增生症患者的健康教育与家庭护理[J]. 医药前沿, 2017, 7(15): 312-313. DOI: 10.3969/j.issn.2095-1752.2017.15.259.
[22] 罗玉红,张发,梁梦天,等.良性前列腺增生继发下尿路症状自我管理干预的研究进展[J].中国医药导报, 2020, 17(24): 40-43.
[23] 付德明.前列腺增生症的药物治疗和自我调理[J].家庭医学(上半月), 2019(12):19.
[24] 刘荣华,王楠.社区护理干预对老年前列腺增生症的影响[J].辽宁医学杂志, 2012, 26(3): 151-152. DOI: 10.3969/j.issn.1001-1722.2012.03.020.
[25] LIU X Y, HUANG G Y, CHEN P J, et al. Comparative effects of Yi Jin Jing versus Tai Chi exercise training on benign prostatic hyperplasia-related outcomes in older adults: study protocol for a randomized controlled trial[J]. Trials, 2016, 17(1): 319. DOI: 10.1186/s13063-016-1448-4.
[26] 黄翔,蔡海荣,施思.中西医结合治疗良性前列腺增生症的临床观察[J].中华中医药学刊, 2017, 35(8): 2196-2198. DOI: 10.13193/j.issn.1673-7717.2017.08.076.
[27] 楼朝飞,陈邦余,朱争鸣.社区管理对老年良性前列腺增生症患者生存质量的影响[J].中国乡村医药, 2009, 16(6): 61-62. DOI: 10.3969/j.issn.1006-5180.2009.06.054.
[28] 李爱东,姚海军,徐煜.前列腺增生症患者社区及与专科医院联合临床管理探讨[J].中国初级卫生保健, 2018, 32(1): 34-36. DOI: 10.3969/j.issn.1001-568X.2018.01.0012.
[29] MIÑANA B, MOLERO J M, ROLÁN A A, et al. Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain[J]. Int J Clin Pract, 2021, 75(8): e14250. DOI: 10.1111/ijcp.14250.
[30] LEIBBRAND M, SIEFER S, SCHÖN C, et al. Effects of an oil-free hydroethanolic pumpkin seed extract on symptom frequency and severity in men with benign prostatic hyperplasia: a pilot study in humans[J].J Med Food,2019, 22(6):551-559.DOI: 10.1089/jmf.2018.0106.
[31] MORDASINI L, MOSCHINI M, MATTEI A, et al. GreenLight laser for benign prostatic hyperplasia[J]. Curr Opin Urol, 2018, 28(3): 322-328. DOI: 10.1097/MOU.0000000000000500.
[32] VASANWALA F F, WONG M Y C, HO H S S, et al. Benign prostatic hyperplasia and male lower urinary symptoms: a guide for family physicians[J]. Asian J Urol, 2017, 4(3): 181-184. DOI: 10.1016/j.ajur.2017.05.003.
[33] SOPEÑA-SUTIL R, TEJIDO-SÁNCHEZ A, DE URBINA M G O, et al. Evolution of primary care referrals to urology. Impact of a protocol on prostate disease and continuing education[J]. Actas Urológicas Españolas Engl Ed, 2015, 39(5): 296-302. DOI: 10.1016/j.acuroe.2015.04.006.
[34] DAS K, BUCHHOLZ N. Benign prostate hyperplasia and nutrition[J]. Clin Nutr ESPEN, 2019, 33: 5-11. DOI: 10.1016/j.clnesp.2019.07.015.
[35] ZENDEHDEL A, ANSARI M, KHATAMI F, et al. The effect of vitamin D supplementation on the progression of benign prostatic hyperplasia: a randomized controlled trial[J]. Clin Nutr, 2021, 40(5): 3325-3331. DOI: 10.1016/j.clnu.2020.11.005.
[36] ELEAZU C, ELEAZU K, KALU W. Management of benign prostatic hyperplasia: could dietary polyphenols be an alternative to existing therapies? [J]. Front Pharmacol, 2017, 8: 234. DOI: 10.3389/fphar.2017.00234.
[37] XIONG Y, ZHANG Y C, LI X Y, et al. The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males[J]. Aging Male, 2020, 23(5): 1432-1439. DOI: 10.1080/13685538.2020.1781806.
[38] PARK H J, PARK C H, CHANG Y, et al. Sitting time, physical activity and the risk of lower urinary tract symptoms: a cohort study[J]. BJU Int, 2018, 122(2): 293-299. DOI: 10.1111/bju.14147.